These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31842300)

  • 1. High-Sensitivity C-Reactive Protein and Acute Kidney Injury in Patients with Acute Myocardial Infarction: A Prospective Observational Study.
    Cosentino N; Genovese S; Campodonico J; Bonomi A; Lucci C; Milazzo V; Moltrasio M; Biondi ML; Riggio D; Veglia F; Ceriani R; Celentano K; De Metrio M; Rubino M; Bartorelli AL; Marenzi G
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31842300
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus.
    Lucci C; Cosentino N; Genovese S; Campodonico J; Milazzo V; De Metrio M; Rondinelli M; Riggio D; Biondi ML; Rubino M; Celentano K; Bonomi A; Capra N; Veglia F; Agostoni P; Bartorelli AL; Marenzi G
    Cardiovasc Diabetol; 2020 Oct; 19(1):183. PubMed ID: 33081810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of N-terminal pro-brain natriuretic peptide and hs-CRP in predicting acute kidney injury after acute myocardial infarction.
    Wang W; Xie Y; Huang X; Zhou Y; Luo L
    Am J Transl Res; 2022; 14(8):5501-5510. PubMed ID: 36105028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein as a predictive factor of acute kidney injury following aneurysmal subarachnoid hemorrhage: a prospective observational study.
    Yang BH; He Q; Ding CY; Kang DZ; Tang QX
    Acta Neurochir (Wien); 2019 Sep; 161(9):1783-1791. PubMed ID: 31317264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Lin XL; Sun HX; Li FQ; Zhao JY; Zhao DH; Liu JH; Fan Q
    Clin Cardiol; 2022 Mar; 45(3):282-290. PubMed ID: 35066901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
    Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
    J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
    Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
    [No Abstract]   [Full Text] [Related]  

  • 11. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction.
    Yip HK; Wu CJ; Chang HW; Yang CH; Yeh KH; Chua S; Fu M
    Chest; 2004 Nov; 126(5):1417-22. PubMed ID: 15539707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Pokharel Y; Sharma PP; Qintar M; Lu Y; Tang Y; Jones P; Dreyer RP; Spertus JA
    Atherosclerosis; 2017 Nov; 266():16-23. PubMed ID: 28946036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction.
    Nozari Y; Geraiely B
    Acta Med Iran; 2011; 49(8):531-5. PubMed ID: 22009810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection].
    Wang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):962-966. PubMed ID: 31537220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of statin treatment in patients with acute myocardial infarction and left ventricular systolic dysfunction according to the level of high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Park KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC; Chae JK; Kim CJ; Rha SW; Jang YS; Oh SK; Seong IW; Cha KS
    Int Heart J; 2014; 55(2):106-12. PubMed ID: 24632965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
    Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some biomarkers in acute myocardial infarction.
    Amiri Majd A; Rezaei M; Goodarzi M; Homayoonfar S
    J Res Health Sci; 2007 Dec; 7(2):11-9. PubMed ID: 23343919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.